BTIG Maintains Buy on Boston Scientific, Raises Price Target to $93

Benzinga · 10/14 16:45
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $84 to $93.